EHMT2 Recombinant Antbody Kit (KD-Validated)
Applications
Reactivity
| Overview | |
| Catalog # | bsm-90322r-50uL |
| Product Name | EHMT2 Recombinant Antbody Kit (KD-Validated) |
| Applications |
WB
FCM
IC
|
| Specificity | Knockdown Validated |
| Reactivity | Human, Mouse, Rat |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | A synthesized peptide derived from human EHMT2 |
| Immunogen Range | 2-300/1210 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Affinity Purified |
| Storage Buffer | 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Storage Condition | -20°C |
| Target | |
| Gene ID | 10919 |
| Swiss Prot | Q96KQ7 |
| Synonyms | Euchromatic Histone Lysine Methyltransferase 2; KMT1C; G9A; C6orf30; BAT8; Euchromatic Histone-Lysine N-Methyltransferase 2; Histone-Lysine N-Methyltransferase EHMT2; Histone H3-K9 Methyltransferase 3; HLA-B Associated Transcript 8; Lysine N-Methyltransferase 1C; H3-K9-HMTase 3; Em:AF134726.3; NG36/G9a; NG36; Histone-Lysine N-Methyltransferase H3 Lysine-9 Specific 3; Chromosome 6 Open Reading Frame 30; Ankyrin Repeat-Containing Protein; G9A Histone Methyltransferase; HLA-B-Associated Transcript 8; EC 2.1.1.367; Protein G9a; EC 2.1.1.-; GAT8 |
| Background | Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution | |
| WB | 1:300-5000 |
| FCM | 1:20-100 |
| IC | 1:1000 |